Crossed from claiming to demonstrating: management marks its own before/after line with repeated, recent proof
The model's full reasoning — Q4 2017 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management convey that company has recently crossed from claiming something to demonstrating it — capability/offering/way of doing business that until recently existed mainly as promise/plan/early attempt is now actually done, and done more than once, in recent period — with management itself drawing before-versus-now contrast? Need identify if management draws own before/after line, after-side real recent repeated, crossing fresh payoff ahead. Let's parse transcript. Management discusses J&J partnership, PEAK programs, educational programs, collaborations, manufacturing scale-up, etc. Need find specific "crossed from claiming to demonstrating" with repeated events. Possible candidates: - J&J partnership: "In just one year, we have created an energy and enthusiasm... resources J&J investing... account activation... PEAK programs... J&J has committed to resourcing a six-fold increase in number of PEAK programs in 2018. In fact the number of PEAK programs already completed or planned so far this year is greater than the number of programs completed all of last year." This is before/after? They had partnership, now activation. But is it "claiming to demonstrating"? Maybe not exactly capability proven? They mention account activation grew, PEAK programs increased. But management doesn't explicitly contrast "we used to talk about, now doing" with repeated real events? They say "In just one year, we have created..." and "number of activated accounts continued to grow." But not necessarily crossing from promise to proof. - Manufacturing: "we continue to invest in expansion... first commercial manufacturing on track to begin in second half of 2018." That's future, not done. - Nerve block sNDA: AdCom vote disappointing, not demonstration. - Phase 4 studies: "currently enrolling patients and we expect data later this year." Not done. - DepoMeloxicam: "submitted IND and expect to begin clinical trials this year." Not done. - CMS reimbursement: "working with CMS" not done. - Partnerships: "we recently entered into several exciting new collaborations" - but these are announcements, not repeated demonstration. - Digital video campaign: "new series" not yet. - PEAK programs: "J&J has committed to resourcing a six-fold increase...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
DXCM · Q4 2023 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES The transcript shows management drawing a clear before/after contrast on the Malaysia manufacturing facility: previously they relied on established US facilities, but mid-year they opened a new site and are now ramping production with yields matching the US ones—real, repeated activity rather than a single event or plan. This is framed as 2023 being transformational, with the new capability already contributing to results and positioned for further scaling ahead. The primary-care expansion also fits as a demonstrated shift from long-term investment to immediate results (70% of new scripts), but the manufacturing crossing is the clearest match to the criteria.
LC · Q4 2021 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES The transcript shows management drawing a clear before/after line: Scott Sanborn describes closing 2021 in the strongest position after executing a strategy laid out in February, creating America's first digital marketplace bank; Tom Casey states the radical transformation over the last year is now complete as promised, contrasting it with 2019 4Q revenue and net income levels to highlight the fundamental change. The after-side is real and repeated—record revenue, doubled economics, NII recurring stream, multiple quarters of strong performance—backed by actual bank operations and deliveries.
KTB · Q3 2021 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES Management draws its own before/after line in Scott Baxter’s opening remarks: “we are doing things with both the Wrangler and Lee brands that we have simply never done before,” directly contrasting past practice with the current reality of new marketing campaigns (Lee launched October, Wrangler September). The after-side is 1) real and recent (Q3 results show 50 % growth in U.S. outdoor and 60 % growth in work wear versus 2019 baselines) and 2) repeated across multiple categories and brands, confirming the capability is now operating rather than a one-off event.